A federal judge has ruled that a qui tam suit on behalf of more than two dozen states, accusing a Johnson & Johnson subsidiary of off-label marketing of HIV/AIDS drugs, can move ahead in pared-down form.
May 31, 2017 at 05:35 PM
1 minute read
A federal judge has ruled that a qui tam suit on behalf of more than two dozen states, accusing a Johnson & Johnson subsidiary of off-label marketing of HIV/AIDS drugs, can move ahead in pared-down form.
U.S. District Judge Michael Shipp, granting in part and denying in part a summary judgment motion, ruled May 30 that some claims against Janssen Products can proceed.
'Old School' Expectations Plague Young Lawyer Mental Health—But Not All Predecessors Are Sympathetic
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
